View Future GrowthPharma Aids 과거 순이익 실적과거 기준 점검 5/6Pharma Aids은 연평균 10%의 비율로 수입이 증가해 온 반면, Packaging 산업은 수입이 5.7% 증가했습니다. 매출은 연평균 11.7%의 비율로 증가했습니다. Pharma Aids의 자기자본이익률은 15.5%이고 순이익률은 15.3%입니다.핵심 정보9.99%순이익 성장률9.99%주당순이익(EPS) 성장률Packaging 산업 성장률2.63%매출 성장률11.66%자기자본이익률15.53%순이익률15.27%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트공시 • Apr 27Pharma Aids Limited to Report Q3, 2026 Results on Apr 29, 2026Pharma Aids Limited announced that they will report Q3, 2026 results on Apr 29, 2026공시 • Jan 26Pharma Aids Limited to Report Q2, 2026 Results on Jan 29, 2026Pharma Aids Limited announced that they will report Q2, 2026 results on Jan 29, 2026공시 • Nov 11+ 1 more updatePharma Aids Limited to Report Q1, 2026 Results on Nov 15, 2025Pharma Aids Limited announced that they will report Q1, 2026 results on Nov 15, 2025공시 • Oct 31Pharma Aids Limited to Report Fiscal Year 2025 Results on Nov 06, 2025Pharma Aids Limited announced that they will report fiscal year 2025 results on Nov 06, 2025공시 • Apr 28Pharma Aids Limited to Report Q3, 2025 Results on Apr 30, 2025Pharma Aids Limited announced that they will report Q3, 2025 results on Apr 30, 2025공시 • Jan 23Pharma Aids Limited to Report Q2, 2025 Results on Jan 30, 2025Pharma Aids Limited announced that they will report Q2, 2025 results on Jan 30, 2025모든 업데이트 보기Recent updates공시 • Apr 27Pharma Aids Limited to Report Q3, 2026 Results on Apr 29, 2026Pharma Aids Limited announced that they will report Q3, 2026 results on Apr 29, 2026공시 • Jan 26Pharma Aids Limited to Report Q2, 2026 Results on Jan 29, 2026Pharma Aids Limited announced that they will report Q2, 2026 results on Jan 29, 2026공시 • Nov 11+ 1 more updatePharma Aids Limited to Report Q1, 2026 Results on Nov 15, 2025Pharma Aids Limited announced that they will report Q1, 2026 results on Nov 15, 2025공시 • Nov 10Pharma Aids Limited, Annual General Meeting, Dec 24, 2025Pharma Aids Limited, Annual General Meeting, Dec 24, 2025, at 11:30 Central Asia Standard Time.공시 • Oct 31Pharma Aids Limited to Report Fiscal Year 2025 Results on Nov 06, 2025Pharma Aids Limited announced that they will report fiscal year 2025 results on Nov 06, 2025공시 • Apr 28Pharma Aids Limited to Report Q3, 2025 Results on Apr 30, 2025Pharma Aids Limited announced that they will report Q3, 2025 results on Apr 30, 2025공시 • Jan 23Pharma Aids Limited to Report Q2, 2025 Results on Jan 30, 2025Pharma Aids Limited announced that they will report Q2, 2025 results on Jan 30, 2025Reported Earnings • Nov 12Full year 2024 earnings released: EPS: ৳19.61 (vs ৳2.05 loss in FY 2023)Full year 2024 results: EPS: ৳19.61 (up from ৳2.05 loss in FY 2023). Revenue: ৳421.2m (up 37% from FY 2023). Net income: ৳61.2m (up ৳67.6m from FY 2023). Profit margin: 14% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.공시 • Nov 12Pharma Aids Limited to Report Q1, 2025 Results on Nov 13, 2024Pharma Aids Limited announced that they will report Q1, 2025 results on Nov 13, 2024New Risk • Nov 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Revenue is less than US$5m (৳409m revenue, or US$3.4m). Market cap is less than US$100m (৳1.92b market cap, or US$16.0m).Declared Dividend • Nov 09Dividend of ৳2.50 announcedShareholders will receive a dividend of ৳2.50. Ex-date: 8th December 2024 Payment date: 23rd January 2025 Dividend yield will be 0.4%, which is lower than the industry average of 1.3%. Payout Ratios Payout ratio: 6%. Cash payout ratio: 11%.공시 • Nov 07Pharma Aids Limited, Annual General Meeting, Dec 24, 2024Pharma Aids Limited, Annual General Meeting, Dec 24, 2024, at 11:30 Central Asia Standard Time.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ৳694, the stock trades at a trailing P/E ratio of 42.6x. Average trailing P/E is 17x in the Packaging industry in Asia. Total returns to shareholders of 32% over the past three years.공시 • Oct 31Pharma Aids Limited to Report Fiscal Year 2024 Results on Nov 06, 2024Pharma Aids Limited announced that they will report fiscal year 2024 results on Nov 06, 2024Reported Earnings • Apr 26Third quarter 2024 earnings released: EPS: ৳7.46 (vs ৳1.21 loss in 3Q 2023)Third quarter 2024 results: EPS: ৳7.46 (up from ৳1.21 loss in 3Q 2023). Revenue: ৳116.7m (up 39% from 3Q 2023). Net income: ৳23.3m (up ৳27.0m from 3Q 2023). Profit margin: 20% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.공시 • Apr 21Pharma Aids Limited to Report Q3, 2024 Results on Apr 24, 2024Pharma Aids Limited announced that they will report Q3, 2024 results on Apr 24, 2024Reported Earnings • Jan 31Second quarter 2024 earnings released: EPS: ৳7.21 (vs ৳0.76 loss in 2Q 2023)Second quarter 2024 results: EPS: ৳7.21 (up from ৳0.76 loss in 2Q 2023). Revenue: ৳120.8m (up 63% from 2Q 2023). Net income: ৳22.5m (up ৳24.9m from 2Q 2023). Profit margin: 19% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.공시 • Jan 26Pharma Aids Limited to Report Q2, 2024 Results on Jan 30, 2024Pharma Aids Limited announced that they will report Q2, 2024 results on Jan 30, 2024Reported Earnings • Nov 14Full year 2023 earnings released: ৳2.05 loss per share (vs ৳11.14 profit in FY 2022)Full year 2023 results: ৳2.05 loss per share (down from ৳11.14 profit in FY 2022). Revenue: ৳308.5m (down 4.5% from FY 2022). Net loss: ৳6.38m (down 118% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.공시 • Nov 09Pharma Aids Limited Recommends Cash Dividend for the Year Ended June 30, 2023Pharma Aids Limited Board of Directors has recommended 10% cash dividend for the year ended June 30, 2023. Date of AGM is December 28, 2023, Record date is December 07, 2023.공시 • Nov 02Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023Pharma Aids Limited announced that they will report fiscal year 2023 results on Nov 07, 2023Reported Earnings • May 02Third quarter 2023 earnings released: ৳1.21 loss per share (vs ৳4.63 profit in 3Q 2022)Third quarter 2023 results: ৳1.21 loss per share (down from ৳4.63 profit in 3Q 2022). Revenue: ৳83.8m (down 2.0% from 3Q 2022). Net loss: ৳3.76m (down 126% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.Reported Earnings • Jan 24Second quarter 2023 earnings released: ৳0.76 loss per share (vs ৳5.53 profit in 2Q 2022)Second quarter 2023 results: ৳0.76 loss per share (down from ৳5.53 profit in 2Q 2022). Revenue: ৳74.2m (down 8.6% from 2Q 2022). Net loss: ৳2.36m (down 114% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.Upcoming Dividend • Dec 04Upcoming dividend of ৳5.00 per shareEligible shareholders must have bought the stock before 11 December 2022. Payment date: 26 January 2023. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Bangladeshi dividend payers (3.8%). Lower than average of industry peers (1.9%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳933, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 39x in the Packaging industry in Bangladesh. Total returns to shareholders of 78% over the past three years.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Feb 02Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: ৳5.53 (up from ৳4.03 in 2Q 2021). Revenue: ৳81.1m (up 20% from 2Q 2021). Net income: ৳17.3m (up 37% from 2Q 2021). Profit margin: 21% (up from 19% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improved over the past weekAfter last week's 26% share price gain to ৳791, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 15x in the Packaging industry in Asia. Total returns to shareholders of 23% over the past three years.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ৳561, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 14x in the Packaging industry in Asia. Total loss to shareholders of 3.4% over the past three years.Upcoming Dividend • Dec 01Upcoming dividend of ৳5.00 per shareEligible shareholders must have bought the stock before 08 December 2021. Payment date: 30 January 2022. Trailing yield: 1.0%. Lower than top quartile of Bangladeshi dividend payers (3.1%). Lower than average of industry peers (2.1%).Is New 90 Day High Low • Feb 15New 90-day low: ৳393The company is down 6.0% from its price of ৳418 on 17 November 2020. The Bangladeshi market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is flat over the same period.Is New 90 Day High Low • Dec 20New 90-day high: ৳472The company is up 1.0% from its price of ৳468 on 21 September 2020. The Bangladeshi market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is down 6.0% over the same period.공시 • Nov 11Pharma Aids Limited, Annual General Meeting, Dec 24, 2020Pharma Aids Limited, Annual General Meeting, Dec 24, 2020, at 11:30 Bangladesh Standard Time.공시 • Nov 10Pharma Aids Limited to Report Q1, 2021 Results on Nov 12, 2020Pharma Aids Limited announced that they will report Q1, 2021 results on Nov 12, 2020공시 • Jul 06Pharma Aids Limited to Report Q3, 2020 Results on Jun 24, 2020Pharma Aids Limited announced that they will report Q3, 2020 results on Jun 24, 2020매출 및 비용 세부 내역Pharma Aids가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DSE:PHARMAID 매출, 비용 및 순이익 (BDT Millions)날짜매출순이익일반관리비연구개발비31 Dec 254747249030 Sep 254536748030 Jun 254386447031 Mar 254175346031 Dec 244326244030 Sep 244316744030 Jun 244216144031 Mar 244095144031 Dec 233762442030 Sep 23329-138030 Jun 23308-637031 Mar 23302-1346031 Dec 22303546030 Sep 223102546030 Jun 223233547031 Mar 223256040031 Dec 213155839030 Sep 213015439030 Jun 212805038031 Mar 212724637031 Dec 202554735030 Sep 202625134030 Jun 202705234031 Mar 202595132031 Dec 192655032030 Sep 192554832030 Jun 192494830031 Mar 192525026031 Dec 182465126030 Sep 182485027030 Jun 182354726031 Mar 182274624031 Dec 172123924030 Sep 171933522030 Jun 171803021031 Mar 171762820031 Dec 161662619030 Sep 161612518030 Jun 161522317031 Mar 161392317031 Dec 151372216030 Sep 151382316030 Jun 1514725150양질의 수익: PHARMAID는 고품질 수익을 보유하고 있습니다.이익 마진 증가: PHARMAID의 현재 순 이익률 (15.3%)은 지난해 (14.5%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: PHARMAID의 수익은 지난 5년 동안 연평균 10% 증가했습니다.성장 가속화: 지난 1년간 PHARMAID 의 수익 증가율(16%)은 연간 평균(10%)을 초과합니다.수익 대 산업: PHARMAID의 지난 1년 수익 증가율(16%)은 Packaging 업계의 3.8%를 상회했습니다.자기자본이익률높은 ROE: PHARMAID의 자본 수익률(15.5%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/14 10:13종가2026/05/14 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Pharma Aids Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 27Pharma Aids Limited to Report Q3, 2026 Results on Apr 29, 2026Pharma Aids Limited announced that they will report Q3, 2026 results on Apr 29, 2026
공시 • Jan 26Pharma Aids Limited to Report Q2, 2026 Results on Jan 29, 2026Pharma Aids Limited announced that they will report Q2, 2026 results on Jan 29, 2026
공시 • Nov 11+ 1 more updatePharma Aids Limited to Report Q1, 2026 Results on Nov 15, 2025Pharma Aids Limited announced that they will report Q1, 2026 results on Nov 15, 2025
공시 • Oct 31Pharma Aids Limited to Report Fiscal Year 2025 Results on Nov 06, 2025Pharma Aids Limited announced that they will report fiscal year 2025 results on Nov 06, 2025
공시 • Apr 28Pharma Aids Limited to Report Q3, 2025 Results on Apr 30, 2025Pharma Aids Limited announced that they will report Q3, 2025 results on Apr 30, 2025
공시 • Jan 23Pharma Aids Limited to Report Q2, 2025 Results on Jan 30, 2025Pharma Aids Limited announced that they will report Q2, 2025 results on Jan 30, 2025
공시 • Apr 27Pharma Aids Limited to Report Q3, 2026 Results on Apr 29, 2026Pharma Aids Limited announced that they will report Q3, 2026 results on Apr 29, 2026
공시 • Jan 26Pharma Aids Limited to Report Q2, 2026 Results on Jan 29, 2026Pharma Aids Limited announced that they will report Q2, 2026 results on Jan 29, 2026
공시 • Nov 11+ 1 more updatePharma Aids Limited to Report Q1, 2026 Results on Nov 15, 2025Pharma Aids Limited announced that they will report Q1, 2026 results on Nov 15, 2025
공시 • Nov 10Pharma Aids Limited, Annual General Meeting, Dec 24, 2025Pharma Aids Limited, Annual General Meeting, Dec 24, 2025, at 11:30 Central Asia Standard Time.
공시 • Oct 31Pharma Aids Limited to Report Fiscal Year 2025 Results on Nov 06, 2025Pharma Aids Limited announced that they will report fiscal year 2025 results on Nov 06, 2025
공시 • Apr 28Pharma Aids Limited to Report Q3, 2025 Results on Apr 30, 2025Pharma Aids Limited announced that they will report Q3, 2025 results on Apr 30, 2025
공시 • Jan 23Pharma Aids Limited to Report Q2, 2025 Results on Jan 30, 2025Pharma Aids Limited announced that they will report Q2, 2025 results on Jan 30, 2025
Reported Earnings • Nov 12Full year 2024 earnings released: EPS: ৳19.61 (vs ৳2.05 loss in FY 2023)Full year 2024 results: EPS: ৳19.61 (up from ৳2.05 loss in FY 2023). Revenue: ৳421.2m (up 37% from FY 2023). Net income: ৳61.2m (up ৳67.6m from FY 2023). Profit margin: 14% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
공시 • Nov 12Pharma Aids Limited to Report Q1, 2025 Results on Nov 13, 2024Pharma Aids Limited announced that they will report Q1, 2025 results on Nov 13, 2024
New Risk • Nov 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Revenue is less than US$5m (৳409m revenue, or US$3.4m). Market cap is less than US$100m (৳1.92b market cap, or US$16.0m).
Declared Dividend • Nov 09Dividend of ৳2.50 announcedShareholders will receive a dividend of ৳2.50. Ex-date: 8th December 2024 Payment date: 23rd January 2025 Dividend yield will be 0.4%, which is lower than the industry average of 1.3%. Payout Ratios Payout ratio: 6%. Cash payout ratio: 11%.
공시 • Nov 07Pharma Aids Limited, Annual General Meeting, Dec 24, 2024Pharma Aids Limited, Annual General Meeting, Dec 24, 2024, at 11:30 Central Asia Standard Time.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ৳694, the stock trades at a trailing P/E ratio of 42.6x. Average trailing P/E is 17x in the Packaging industry in Asia. Total returns to shareholders of 32% over the past three years.
공시 • Oct 31Pharma Aids Limited to Report Fiscal Year 2024 Results on Nov 06, 2024Pharma Aids Limited announced that they will report fiscal year 2024 results on Nov 06, 2024
Reported Earnings • Apr 26Third quarter 2024 earnings released: EPS: ৳7.46 (vs ৳1.21 loss in 3Q 2023)Third quarter 2024 results: EPS: ৳7.46 (up from ৳1.21 loss in 3Q 2023). Revenue: ৳116.7m (up 39% from 3Q 2023). Net income: ৳23.3m (up ৳27.0m from 3Q 2023). Profit margin: 20% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.
공시 • Apr 21Pharma Aids Limited to Report Q3, 2024 Results on Apr 24, 2024Pharma Aids Limited announced that they will report Q3, 2024 results on Apr 24, 2024
Reported Earnings • Jan 31Second quarter 2024 earnings released: EPS: ৳7.21 (vs ৳0.76 loss in 2Q 2023)Second quarter 2024 results: EPS: ৳7.21 (up from ৳0.76 loss in 2Q 2023). Revenue: ৳120.8m (up 63% from 2Q 2023). Net income: ৳22.5m (up ৳24.9m from 2Q 2023). Profit margin: 19% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
공시 • Jan 26Pharma Aids Limited to Report Q2, 2024 Results on Jan 30, 2024Pharma Aids Limited announced that they will report Q2, 2024 results on Jan 30, 2024
Reported Earnings • Nov 14Full year 2023 earnings released: ৳2.05 loss per share (vs ৳11.14 profit in FY 2022)Full year 2023 results: ৳2.05 loss per share (down from ৳11.14 profit in FY 2022). Revenue: ৳308.5m (down 4.5% from FY 2022). Net loss: ৳6.38m (down 118% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.
공시 • Nov 09Pharma Aids Limited Recommends Cash Dividend for the Year Ended June 30, 2023Pharma Aids Limited Board of Directors has recommended 10% cash dividend for the year ended June 30, 2023. Date of AGM is December 28, 2023, Record date is December 07, 2023.
공시 • Nov 02Pharma Aids Limited to Report Fiscal Year 2023 Results on Nov 07, 2023Pharma Aids Limited announced that they will report fiscal year 2023 results on Nov 07, 2023
Reported Earnings • May 02Third quarter 2023 earnings released: ৳1.21 loss per share (vs ৳4.63 profit in 3Q 2022)Third quarter 2023 results: ৳1.21 loss per share (down from ৳4.63 profit in 3Q 2022). Revenue: ৳83.8m (down 2.0% from 3Q 2022). Net loss: ৳3.76m (down 126% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.
Reported Earnings • Jan 24Second quarter 2023 earnings released: ৳0.76 loss per share (vs ৳5.53 profit in 2Q 2022)Second quarter 2023 results: ৳0.76 loss per share (down from ৳5.53 profit in 2Q 2022). Revenue: ৳74.2m (down 8.6% from 2Q 2022). Net loss: ৳2.36m (down 114% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.
Upcoming Dividend • Dec 04Upcoming dividend of ৳5.00 per shareEligible shareholders must have bought the stock before 11 December 2022. Payment date: 26 January 2023. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Bangladeshi dividend payers (3.8%). Lower than average of industry peers (1.9%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳933, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 39x in the Packaging industry in Bangladesh. Total returns to shareholders of 78% over the past three years.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Feb 02Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: ৳5.53 (up from ৳4.03 in 2Q 2021). Revenue: ৳81.1m (up 20% from 2Q 2021). Net income: ৳17.3m (up 37% from 2Q 2021). Profit margin: 21% (up from 19% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improved over the past weekAfter last week's 26% share price gain to ৳791, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 15x in the Packaging industry in Asia. Total returns to shareholders of 23% over the past three years.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ৳561, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 14x in the Packaging industry in Asia. Total loss to shareholders of 3.4% over the past three years.
Upcoming Dividend • Dec 01Upcoming dividend of ৳5.00 per shareEligible shareholders must have bought the stock before 08 December 2021. Payment date: 30 January 2022. Trailing yield: 1.0%. Lower than top quartile of Bangladeshi dividend payers (3.1%). Lower than average of industry peers (2.1%).
Is New 90 Day High Low • Feb 15New 90-day low: ৳393The company is down 6.0% from its price of ৳418 on 17 November 2020. The Bangladeshi market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is flat over the same period.
Is New 90 Day High Low • Dec 20New 90-day high: ৳472The company is up 1.0% from its price of ৳468 on 21 September 2020. The Bangladeshi market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is down 6.0% over the same period.
공시 • Nov 11Pharma Aids Limited, Annual General Meeting, Dec 24, 2020Pharma Aids Limited, Annual General Meeting, Dec 24, 2020, at 11:30 Bangladesh Standard Time.
공시 • Nov 10Pharma Aids Limited to Report Q1, 2021 Results on Nov 12, 2020Pharma Aids Limited announced that they will report Q1, 2021 results on Nov 12, 2020
공시 • Jul 06Pharma Aids Limited to Report Q3, 2020 Results on Jun 24, 2020Pharma Aids Limited announced that they will report Q3, 2020 results on Jun 24, 2020